Clinical trials
Muscular Atrophy, Spinal trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Active, not recruiting | 5 |
| Recruiting | 4 |
| Enrolling by invitation | 2 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 12 |
| Hoffmann-La Roche | 6 |
| LMU Klinikum | 2 |
| Scholar Rock, Inc. | 2 |
| University of Erlangen-Nürnberg Medical School | 2 |
| Alcyone Therapeutics, Inc | 1 |
| Biohaven Pharmaceuticals, Inc. | 1 |
| Charite University, Berlin, Germany | 1 |
| Cystinose Stiftung | 1 |
| Institut de Myologie, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy, Spinal | 36 |
| Neuromuscular Diseases | 7 |
| Spinal Muscular Atrophies of Childhood | 5 |
| Amyotrophic Lateral Sclerosis | 3 |
| Atrophy | 2 |
| Friedreich Ataxia | 2 |
| Glycogen Storage Disease Type II | 2 |
| Guillain-Barre Syndrome | 2 |
| Hereditary Sensory and Motor Neuropathy | 2 |
| Lambert-Eaton Myasthenic Syndrome | 2 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.